Jiří Špaček - Concepedia

Author

Jiří Špaček

University Hospital Hradec Králové ORCID

Also Known As

J Spacek, J Spaček, J Špaček, J. Spacek, J. Špaček, Jiri Spacek, Jiri Špaček, Jirí Špacek, Jirí špacek, Jiří Spaček

104

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University Hospital Hradec Králové Charles University Palacký University Olomouc University Hospital Brno Masaryk Memorial Cancer Institute

JŠ

About

Jiří Špaček is an author at University Hospital Hradec Králové specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	851
2	Obstetrics	4	4	651
3	Health Sciences	2	2	78
4	Cell Biology	1	1	64
5	Gastroenterology	1	1	28

Jiří Špaček

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial Amit M. Oza, David Cibula, Ana Oaknin Benzaquen, The Lancet Oncology MedicineRandomised Phase 2GynecologyCancer TreatmentOncology	2014	540
Antibiotic administration reduces the rate of intraamniotic inflammation in preterm prelabor rupture of the membranes Marián Kacerovský, Roberto Romero, Martin Štěpán, American Journal of Obstetrics and Gynecology InflammationAntibiotic AdministrationAntimicrobial SusceptibilityAntibioticsPreterm Labor	2020	97
Olaparib plus paclitaxel plus carboplatin (P/C) followed by olaparib maintenance treatment in patients (pts) with platinum-sensitive recurrent serous ovarian cancer (PSR SOC): A randomized, open-label phase II study. Amit M. Oza, David Cibula, Ana Oaknin, Journal of Clinical Oncology GynecologyPharmacotherapyGynecology OncologyOvarian CancerOlaparib Capsules	2012	67
Methylation in the p53 promoter in epithelial ovarian cancer Marcela Chmelařová, E Křepinská, Jiří Špaček, Clinical & Translational Oncology Epigenetic ChangeP53 PromoterEpigenomicsCancer GeneticsMedicine	2012	64
A Comparison of Dequalinium Chloride Vaginal Tablets (Fluomizin®) and Clindamycin Vaginal Cream in the Treatment of Bacterial Vaginosis: A Single-Blind, Randomized Clinical Trial of Efficacy and Safety E. R. Weissenbacher, Gilbert Donders, Vít Unzeitig, Gynecologic and Obstetric Investigation	2011	62
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in patients with endometrial carcinoma. Petra Čermáková, Bohuslav Melichar, M Tomšová, PubMed	2014	54
Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial Lukáš Rob, David Cibula, Paweł Knapp, Journal for ImmunoTherapy of Cancer	2022	50
Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial David Cibula, Lukáš Rob, Peter Mallmann, Gynecologic Oncology	2021	44
Clinical aspects and luteal phase assessment in patients with recurrent vulvovaginal candidiasis Jiří Špaček, Vladimı́r Buchta, Petr Jílek, European Journal of Obstetrics & Gynecology and Reproductive Biology Vulvar DiseasesGynecologyVaginitisClinical MycologyLuteal Phase Assessment	2006	33
The serum levels of calcium, magnesium, iron and zinc in patients with recurrent vulvovaginal candidosis during attack, remission and in healthy controls Jiří Špaček, Petr Jílek, Vladimı́r Buchta, Mycoses	2005	31

Page 1